Background: Fatigue is a major symptom of rheumatoid arthritis (RA) and the need for
Introduction
Rheumatoid arthritis (RA) is a chronic, inflammatory autoimmune disease, predominantly affecting peripheral joints 1 . RA affects 1.16% of women and 0.44% of men in the United Kingdom 2 . It is a progressive, systemic disease associated with considerable morbidity and increased mortality [3] [4] [5] .
Fatigue has been identified as an important symptom of RA, causing distress and disruption to patients' daily lives and affecting everyday tasks and leisure activities [6] [7] [8] .
Reported rates of fatigue in RA vary, possibly due to differences in definition and outcome measurement, but may be as high as 80% 9, 10 . Many patients with RA report that they find it difficult to manage fatigue, and receive little professional support 6, 11 .
The mechanisms and causality of fatigue in RA remain unclear due to its complex and multi-factorial nature. However, it has been suggested that interactions between RA disease processes (e.g. inflammation, pain, disability, muscle effort and deconditioning), thoughts, feelings and behaviours (e.g. illness beliefs, anxiety and depression), and personal life factors (e.g. work, health, support networks) might influence a person's fatigue experience 12 . Recent multivariate analyses demonstrated that higher disease activity, poor sleep, depression and obesity are independent predictors of RA fatigue 13 .
Description of the intervention
Clinical guidelines for managing RA recommend non-pharmacological approaches to reduce the impact of physical and psychosocial factors associated with RA [14] [15] [16] . These approaches include physical activity (PA) interventions to enhance self-management and coping skills.
PA interventions may also be used to manage RA fatigue, aiming to improve engagement in lifestyle PA, such as walking to work, or more formal prescribed exercise programmes.
Interventions may specify PA components such as type, intensity, duration and frequency.
For example, some might specify aerobic exercise, such as walking or cycling, or other forms of exercise, such as resistance training or yoga. Prescribed PA or exercise programmes might specify a target duration, intensity and/or frequency. In addition the intervention might take place in a wide range of settings and may be land-or pool-based, such as hydrotherapy, and may or may not be supervised by a healthcare or exercise professional. Delivery may be oneto-one or in groups.
Programmes based upon physical activity (PA) have been shown to improve patient reported fatigue in other long term conditions, such as chronic fatigue syndrome 17 and cancer-related fatigue 18 . Therefore the effectiveness of existing PA and exercise interventions for reducing RA fatigue warrants further exploration.
How the intervention might work
A previous Cochrane review 19 suggested that PA interventions have the potential to reduce fatigue in RA. Physical inactivity has been significantly associated with RA fatigue, and its effects appear to be mediated by a range of non-RA-specific variables that are important predictors of fatigue, for example, poor sleep quality, depressive symptoms and obesity 13 .
Therefore PA interventions may affect fatigue through their influence on RA disease processes and other psychosocial and lifestyle factors 12 23 . Regular participation in PA might reduce the impact of RA fatigue by moderating these associated risk factors 13 .
Why it is important to do this review
There are currently few published trials primarily investigating interventions for RA fatigue.
The search conducted in a Cochrane review identified research reports up to October 2012 19 .
The review presented in this paper aimed to identify evidence that has been published since this date, and to ascertain key components of PA interventions that might be used to manage RA fatigue.
Methods
Methods were based on a Cochrane review for non-pharmacological interventions for fatigue in RA 17 .
Criteria for considering studies for this review
Randomised controlled trials (RCTs) of interventions for adults with confirmed RA 24 , with fatigue reported as a primary or secondary outcome measure and data reported separately for RA, were included. Where studies reported outcomes for rheumatic conditions or diseases as one population these data were excluded. In addition, included studies must have investigated a PA intervention.
Search methods for identification of studies
The search strategy for the Cochrane review was repeated with the addition of search terms to identify PA interventions ( 
Data collection and analysis

Selection of studies
Titles and abstracts were screened for inclusion criteria by two reviewers (FC, VS). Full text reports were retrieved where studies appeared to meet these criteria, or where it was unclear whether a study should be excluded from the abstract or title alone. Potentially relevant reports were discussed between reviewers, one of whom was also first author on the Cochrane review (FC) 19 . Data from conference abstracts were not included in the current review unless corresponding full text articles were available. Abstract authors were not contacted.
Data extraction and management
Data were extracted from newly identified studies by one reviewer (VS) using a data extraction form modified from the original Cochrane review, and included: intervention details; participants' health status; assignment to study arm; outcome measures; timing of measurements; adherence to intervention and control; sample size; statistical analysis methods; results for fatigue outcomes; and long-term follow-up data.
Risk of bias
Risk of bias was assessed using the Cochrane risk of bias tool
Measures of treatment effect
The Cochrane review used a meta-analysis to combine mean change scores from pre-to posttest for five of the included PA studies 19 . The Cochrane handbook advises that a new metaanalysis incorporating data from newly identified and included studies should only be performed if deemed appropriate by review authors 26 . It was decided that data from additional studies would be incorporated into the meta-analysis if the size of the treatment effect, indicated by standardised mean difference (SMD), differed sufficiently that it would strengthen or alter the existing conclusions. If effect sizes were not available these would be calculated from the published data using methods described in the Cochrane handbook, section 7.7.3.3 26 . Methodological quality of included studies would be considered when making this decision. Figure 1 illustrates the study selection process.
Results
Results of the search
The six studies investigating PA in the original Cochrane review were retrieved 27-32 .
Following removal of duplicates an additional 44 studies were identified using the keyword search. After title screening 20 articles remained, with seven remaining after screening of abstracts. Of these seven, four were conference abstracts and were not included in this review [33] [34] [35] [36] . Another study was not an RCT 37 . Two studies were included 38, 39 . 
Description of studies
The eight included studies are described in table 2. All studies reported disease duration with the mean ranging from 8 months to 16 years.
Interventions
Interventions are summarised in table 2.
Length of intervention
Six interventions were 12 weeks in length, one was six weeks 28 and another was 24 months 29 .
Type of physical activity
The type of PA included in the interventions varied, and included aerobic exercise 30 32, 38 . In one study the control arm also performed range of movement and stretching exercises alongside usual recreational PA 29 .
Frequency and duration of physical activity
Exercises were generally performed two to three times weekly for both class-and homebased interventions. Daily range of movement exercises and walking at least five times weekly was encouraged in one study 38 . Another study encouraged aerobic PA five days per week 39 . The duration of exercise sessions across the studies varied from 15 to 90 minutes.
One study 29 focussed on strength training, therefore the number of sets and repetitions were targeted rather than exercise duration.
Intensity of physical activity
Aerobic exercise intensity was targeted at 70-90% maximum heart rate in three studies 27, 30, 31 . Two studies reported a more general target of light-to moderate-intensity walking, where participants felt moderately short of breath 38 , or moderate-to vigorous-intensity aerobic PA 39 .
Interventions that included resistance training set a target intensity of either 40-50% 38 or 50-70% 29 repetition maximum. Of those studies reporting a prescribed aerobic intensity, two
reported that adherence to the intensity was not known 27, 31 . The remaining studies did not adequately describe adherence to PA intensity therefore this is unknown.
Intervention delivery
Exercise interventions were often supervised, although three studies investigated the effects of either an unsupervised home exercise programme 31, 38 or tailored PA 39 . One study reported that a physiotherapist guided initial exercises 29 , but it was unclear whether ongoing exercise was performed with or without supervision. Not all studies described the professional background of the person delivering the intervention. Where reported, physiotherapists 27, 29, 39 , a yoga instructor 28 or physical education graduate students 30 provided supervision.
Intervention adherence
Intervention adherence was reported in four studies. These included a mean attendance rate at sessions of 96% 28 and 78% 27 , median number of sessions attended as 30 out of 36 for both class and home exercise groups 31 , and mean exercise frequency as 1.5 times weekly in months zero to 12, and 1.4 times weekly in months 13 to 24 29 . Adherence data for this last study were collected via self-reported exercise diaries, therefore the authors acknowledged that they may be subject to recall bias and inaccurate reporting 29 .
Outcome measures
A range of self-reported fatigue outcome measures was used. Three studies used two scales 28, 32, 39 . Two studies reported fatigue as a primary outcome measure 38, 39 . The primary outcome was not identified in three studies [29] [30] [31] . No details were provided in relation to the design and development of PA interventions, although one study stated that the "goal of the intervention was, in partnership between participant and physical therapist, to devise a mutually agreed self-care plan that guided the participant in managing his or her fatigue" 39 (p. 29).
Participants were selected for the presence of fatigue in only one study 39 .
Adverse events
Only one study explicitly reported that there were no adverse events associated with the intervention 32 . None of the remaining studies reported adverse events. It is unclear whether this was due to a true absence of adverse events or poor reporting.
Risk of bias
Overall, four studies met three criteria 27, 31, 32, 39 , three met two criteria 28, 29, 38 , and one met one criterion 30 for low risk of bias (table 3) . The percentage risk of bias for each domain across all studies is presented in figure 2 . Table 3 . Risk of bias summary for included studies (n=8) Figure 2 : Risk of bias presented as percentages for included studies (n=8)
Random sequence generation and allocation concealment (selection bias)
Random sequence generation was adequately described in five studies. Randomisation was performed using computer-generated random numbers 27, 32, 38, 39 or an a priori list of randomly generated permutations of three numbers 31 . Three studies adequately reported allocation concealment. Methods included patients independently choosing a time slot prior to randomisation 30 and use of sealed opaque envelopes 32, 39 .
Blinding (performance and detection bias)
Blinding of participants, personnel and assessors was not reported in three studies 29, 30, 38 . The remaining five studies reported blinding of outcome assessors only 27, 28, 31, 32, 39 .
Incomplete outcome data (attrition bias)
The majority of studies (n=6) were considered at low risk of attrition bias, reporting all outcome data and giving reasons for missing data. The remaining studies either did not explain missing data for three participants who withdrew and no fatigue data were presented for controls 30 , or no data were provided for withdrawals between randomisation and baseline 31 .
Selective outcome reporting (reporting bias)
Selective reporting was noted in four studies [30] [31] [32] 39 . Outcome data for three intervention arms were combined in one study, thus providing insufficient detail regarding the effect of each intervention 30 . One study reported collecting social support data 31 and another collecting information about medications 39 but did not report these in the published article. The third study reported recording the number of and reasons for missing both intervention and control arm sessions, but did not present these data 32 .
Other sources of bias
Only one study was considered free from other sources of bias as specified for this review 31 .
Of the remaining six studies, three were considered at high risk 28, 29, 32 and four had unclear risk of bias from other sources 27, 30, 38, 39 (table 4). 40 . The remaining two studies did not report statistically significant improvements, with one study only recording subjective improvements in fatigue 30 .
Meta-analysis
In the Cochrane review mean change scores from pre-to post-test were combined in a metaanalysis for six comparisons from five of the six original RCTs 27-29, 31, 32 . One study included two intervention arms enabling two comparisons 31 . Change data for fatigue were not available for the sixth study 30 . Results from the six original comparisons indicated that PA was statistically more effective than control immediately post-intervention (SMD -0.36, 95%
CI -0.62 to -0.10, p=0.0066), indicating a small beneficial effect of PA on fatigue 19 .
In this updated review a summary effect size was not presented for one of the additional included studies 38 . SMD for fatigue outcome was calculated as -0.47, unadjusted for baseline differences, indicating a small effect. When calculating SMD for the study, errors in the data were noted making it difficult to trust the accuracy of the results. Therefore this study was not included in the meta-analysis. Although the SMD was slightly larger than that obtained in the Cochrane review, methodological concerns meant it would not strengthen or alter the original conclusions. The second study included in the updated review reported a summary effect size for VAS fatigue and the Bristol Rheumatoid Arthritis Fatigue MultiDimensional Questionnaire (BRAF-MDQ) 41, 42 . Where more than one fatigue outcome was reported for a study in the original Cochrane review VAS data were included in the metaanalysis 19 . The second study included in the updated review reported a summary effect size of 0.37 for VAS fatigue suggesting a small beneficial effect 39 . As the size of the treatment effect was very similar to that of the original review it was decided that there was no need to repeat the meta-analysis.
Long-term follow-up
One study re-assessed outcomes two months after treatment 28 . Significant post-treatment effects of the intervention on fatigue were not maintained at 2-month follow-up. In another study post-treatment effects of the intervention on VAS fatigue and BRAF-MDQ total fatigue scores were no longer significant six months after baseline 39 . However, significant improvements in the BRAF-MDQ physical fatigue and living with fatigue subscales were maintained (p<0.05). Follow-up data were not available for any other studies.
Discussion
This review investigated the effectiveness of PA interventions for reducing RA fatigue. Eight
RCTs investigating PA interventions and including a fatigue outcome measure were included, providing data for 540 adults with RA. A previous meta-analysis incorporating data from five of the eight studies demonstrated a small significant effect for PA when compared with a control intervention, suggesting that PA may be useful for managing fatigue in RA in the short-term 19 . This update identified two new RCTs that reported statistically significant changes in fatigue outcomes following a home exercise intervention (p=0.04) 38 and a personcentred physical therapy intervention focused on tailoring health-enhancing PA (p<0.05) 39 compared with controls. However, poor methodological quality and reporting errors, and similar effect sizes meant that inclusion of new data in the meta-analysis was not warranted.
The limited follow-up data for included studies limits our understanding of any ongoing effects of PA on RA fatigue.
Components of PA interventions identified in this review included type of PA, mode of delivery, intervention length and duration, frequency and intensity of PA. Interventions were varied and included land-and pool-based aerobic exercise, yoga, Tai Chi and resistance training. Evidence from other long-term conditions suggests that aerobic exercise may be particularly beneficial for managing fatigue 18 . Delivery methods included supervised class programmes, unsupervised home exercise and individual person-centred physical therapy.
Intervention length was reasonably consistent, with the majority lasting 12 weeks. This is similar to the length of PA interventions for managing fatigue in chronic fatigue syndrome 17 .
Several studies prescribed the intensity, duration and frequency of PA. These varied between interventions and it is unclear whether these parameters were successfully adhered to throughout the intervention period. Overall, there was insufficient information from these interventions to judge whether specific PA parameters are more or less likely to be effective for fatigue management in RA. This is a common issue, and data regarding dose response for exercise in general are rarely available. Considerable variation in the intensity, duration and frequency of PA sessions for fatigue management in other long-term conditions has also been reported 17, 18 , although it has been suggested that commencing PA at a lower intensity might be more effective in the treatment of chronic fatigue syndromeInformation regarding overall adherence to PA interventions was limited, making it difficult to determine reasons for participation or non-participation in these programmes. PA research relies on voluntary participation. Consequently, recruitment is often biased towards those who are interested in or motivated to perform PA 44 . Self-selection of participants in PA trials also has implications for the control arm. As a sub-group of motivated participants, they might be more likely to engage in PA even if they have been asked not to, thus increasing the potential for contamination and reducing potential effect size for the PA intervention. This limits external validity of the findings.
Reasons for declining participation in the included studies were often not reported.
Where they were, reasons included being busy, travel distance or disinterest 28 . These reasons have been cited in other PA trials in RA 44, 45 . An in-depth analysis of participants and nonparticipants in a recent PA trial in RA concluded that only 8% of the initial target population
were assessed at baseline, despite 62% expressing interest prior to receiving information about location, timing and cost of the PA interventions 44 . It is possible that PA interventions only reach a small minority of eligible participants in clinical practice.
The included studies were of moderate methodological quality, with small group sizes and lack of blinding being particularly problematic. Three studies reported a sample size calculation 31, 38, 39 but only one was based upon fatigue as the primary outcome 39 . It was unclear whether other studies reporting significant changes in fatigue were adequately powered to detect changes in these outcomes. Small samples and lack of statistical power limit the ability to generalise results to the wider RA population.
Blinding of participants is often not possible for PA interventions 46 , and the use of self-reported questionnaires for measuring fatigue outcome negates the usefulness of blinding the outcome assessor. Therefore, risk of performance and detection bias is difficult to minimise for these interventions. Nonetheless, attempts to minimise this risk were only reported in one study 39 . Poor reporting was noted in several papers, making it difficult to determine the overall quality of the research. The majority of studies were at high risk of bias from sources such as contamination between groups, further limiting the internal validity of the research findings, for example, where control participants performed range of movement and stretching exercises alongside recreational PA 29 .
Only two of the interventions specifically aimed to manage fatigue 38, 39 , although descriptions of intervention design and development processes were minimal for all studies.
Similarly, only one study selected participants for the presence of fatigue 39 , therefore this symptom may not have been a significant problem for participants in other studies.
Consequently, these fatigue data are likely to underestimate the effectiveness of PA for RA fatigue management, as fatigue has been cited as a barrier to PA 47 . Participants who withdrew from a recent PA trial between agreeing to take part and baseline assessment reported more fatigue than those who were assessed (p=0.009) 44 . It is possible that eligible patients who experienced greater fatigue declined participation in studies included in this review and the resulting participants might be less representative of fatigued patients with RA. As a result, the true effectiveness of PA for reducing fatigue in RA is difficult to determine.
Variations in participant characteristics in included studies may further limit the external validity of the results. This includes imbalances in gender, with the inclusion of women only in two studies and fewer men included overall. Although RA affects more women than men 2 , men tend to be under-represented in PA trials in RA 44, 48 . Also, men with RA may require different support strategies than women 49 . As a result, recruitment of predominantly women to a PA intervention may not simply be indicative of gender differences in prevalence rates of RA, but may also reflect different coping styles and management preferences. It cannot be presumed, therefore, that these PA interventions would be effective for reducing fatigue in both men and women with RA.
The range of ages included in studies was also not representative of the general RA population. Peak age of incidence in the UK has been reported as 55-64 years old in women and 65-75 years old in men 2 . However, only three studies reported the average age of participants as falling within the fifth and sixth decades, and none in the seventh decade. This may reflect other observations that participants in PA trials tend to be younger 44, 45 .
Limitations of the review
There are several limitations to the current review. Conference abstracts were excluded, study authors were not contacted and grey literature was not searched. This may have resulted in omission of relevant data.
Only one reviewer (VS) completed data extraction and critical appraisal of the new studies in this update. However, overall results were discussed with a second reviewer (FC) who had been involved with the original review, and all authors were familiar with the eight papers and contributed to the review write-up. Similarly, the Cochrane meta-analysis was not revised to include data from additional studies. However, their inclusion is unlikely to have altered the current conclusions. Finally, the search was limited to RCTs in order to determine effectiveness of the interventions of interest. By limiting the search in this way potentially useful evidence from non-randomised and qualitative studies will have been missed.
Conclusions
Although there is some evidence from a previous meta-analysis of the potential for PA to be effective in reducing symptoms of fatigue in RA 19 , this evidence remains limited. Since publication of the original Cochrane review, two further RCTs have been published, also suggesting a positive effect of exercise on fatigue 38, 39 . However, methodological flaws and poor reporting undermine the trustworthiness of these findings. Additionally, only two of the PA interventions in the included studies specifically aimed to manage RA fatigue, and few participants were selected to take part in the studies based on their fatigue experience, making it difficult to establish the true effectiveness of these interventions for managing RA fatigue.
Further research is needed to identify the optimal PA intervention, including key components and parameters such as type and intensity of PA, for managing fatigue for people with RA. 28 Feldthusen, 29 Harkcom, 30 Neuberger, 28 Feldthusen, 29 Harkcom, 30 Neuberger, 28 Feldthusen, 29 Harkcom, 30 Neuberger, 
